期刊
JOURNAL OF ORGANIC CHEMISTRY
卷 87, 期 7, 页码 4813-4817出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.2c00083
关键词
-
资金
- National Research Foundation of Korea (NRF) - Korean Government [NRF-2021R1A2C1012984, NRF2021R1A5A6002803]
This study reports a concise total synthesis of rucaparib, an FDA-approved drug for ovarian and prostate cancers. The desired structure was achieved through key reactions, and the final compound was obtained with commercially available starting materials in a simple procedure, resulting in a high overall yield.
A concise total synthesis of rucaparib, an FDA-approved drug for ovarian and prostate cancers, is reported. TheHeck reaction of the commercially available aryl iodide withacrylonitrile provided the desired (E)-2-aminocinnamonitrile deriva-tive. A subsequent imino-Stetter reaction of the aldimine derived from2-aminocinnamonitrile and aldehyde furnished indole-3-acetonitrilebearing the desired substituents at appropriate positions. Theconstruction of thefinal azepinone scaffold via reduction of thenitrile group followed by seven-membered lactamization affordedrucaparib. Notably, the synthesis of rucaparib is achieved usingcommercially available starting materials in only three separationoperations with 54% overall yield.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据